FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, specifically to oncology, and concerns the treatment of chordoma. To this end, an individual who has chordoma is administered an immunotherapeutic composition containing: a) a yeast vehicle and b) a cancer antigen comprising at least one brachyury antigen, where said brachyury antigen has an amino acid sequence represented by SEQ ID NO: 6, SEQ ID NO: 18 or SEQ ID NO: 2. Also disclosed is the use of the said immunotherapeutic composition for the treatment of chordoma.
EFFECT: group of inventions provides effective medical treatment of chordoma.
38 cl, 1 dwg, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOTHERAPEUTIC COMPOSITIONS BASED ON YEAST WITH BRACHYURY | 2012 |
|
RU2619850C2 |
| IMMUNOTHERAPEUTIC COMPOSITIONS ON THE BASIS OF YEAST-MUC1 AND METHODS OF THEIR USE | 2012 |
|
RU2642300C2 |
| YEAST-BASED IMMUNOTHERAPEUTIC COMPOSITIONS WITH BRACHYURY | 2012 |
|
RU2690180C2 |
| PHOSPHODIESTERASE 4D7 AS PROSTATE CANCER MARKER | 2010 |
|
RU2651474C2 |
| PHOSPHODIESTERASE 9A AS MARKER OF MALIGNANT TUMOR OF PROSTATE GLAND | 2010 |
|
RU2592668C2 |
| PHOSPHODIESTERASE 4D7 AS MARKER FOR AGGRESSIVE HORMONE-SENSITIVE PROSTATE CANCER | 2010 |
|
RU2575076C2 |
| TREATING CANCER BY HUMANISED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR | 2014 |
|
RU2711975C2 |
| CANCER TREATMENT USING CHIMERIC ANTIGEN-SPECIFIC RECEPTOR BASED ON HUMANISED ANTI-EGFRvIII ANTIBODY | 2014 |
|
RU2708032C2 |
| ANTIBODIES SPECIFIC TO TUMOUR AND USE THEREOF | 2011 |
|
RU2595403C2 |
| COMPOSITIONS COMPRISING ANTIBODY TO CD38 AND CARFILZOMIB | 2014 |
|
RU2670127C2 |
